Patent details

EP2668212 Title: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS

Basic Information

Publication number:
EP2668212
PCT Application Number:
EP2012051320
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP127017424
PCT Publication Number:
WO2012101252
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
French Title of Invention:
ANTICORPS HUMAINS CONTRE PCSK9 POUR UTILISATION DANS DES PROCÉDÉS DE TRAITEMENT DE GROUPES PARTICULIERS DE SUJETS
German Title of Invention:
MENSCHLICHE ANTIKÖRPER GEGEN PSCK9 ZUR VERWENDUNG IN VERFAHREN ZUR BEHANDLUNG BESTIMMTER GRUPPEN VON PERSONEN
SPC Number:

Dates

Filing date:
27/01/2012
Grant date:
21/03/2018
EP Publication Date:
04/12/2013
PCT Publication Date:
02/08/2012
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/03/2018
EP B1 Publication Date:
21/03/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
27/01/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
14/03/2018
 
 

Name:
Sanofi Biotechnology
Address:
54 rue La Boétie, 75008 Paris, France (FR)

Agent

Name:
ARONOVA S.A.
From:
20/06/2018
Address:
PO Box 327, 4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
BESSAC, Laurence
Address:
France (FR)

2

Name:
HANOTIN, Corinne
Address:
France (FR)

3

Name:
CHAUDHARI, Umesh
Address:
United States (US)

Priority

1

Priority Number:
11305088
Priority Date:
28/01/2011
Priority Country:
European Patent Office (EPO) (EP)

2

Priority Number:
11305089
Priority Date:
28/01/2011
Priority Country:
European Patent Office (EPO) (EP)

3

Priority Number:
11305514
Priority Date:
29/04/2011
Priority Country:
European Patent Office (EPO) (EP)

4

Priority Number:
11305513
Priority Date:
29/04/2011
Priority Country:
European Patent Office (EPO) (EP)

5

Priority Number:
11306039
Priority Date:
12/08/2011
Priority Country:
European Patent Office (EPO) (EP)

6

Priority Number:
11306040
Priority Date:
12/08/2011
Priority Country:
European Patent Office (EPO) (EP)

7

Priority Number:
11306201
Priority Date:
22/09/2011
Priority Country:
European Patent Office (EPO) (EP)

8

Priority Number:
11306202
Priority Date:
22/09/2011
Priority Country:
European Patent Office (EPO) (EP)

9

Priority Number:
11306450
Priority Date:
08/11/2011
Priority Country:
European Patent Office (EPO) (EP)

10

Priority Number:
11306449
Priority Date:
08/11/2011
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61J 1/05; A61K 31/215; A61K 31/366; A61K 31/395; A61K 31/404; A61K 31/435; A61K 31/47; A61K 31/505; A61K 39/00; A61K 39/395; A61K 45/06; C07K 14/47; C07K 16/40;

Publication

European Patent Bulletin

1

Issue number:
201812
Publication date:
21/03/2018
Description:
Grant (B1)

2

Issue number:
201817
Publication date:
25/04/2018
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
01/02/2027
Annual Fee Number:
16
Annual Fee Amount:
230 Euro
Expected Payer:
Last Annual Fee Payment Date:
16/01/2026
Last Annual Fee Paid Number:
15
Last Annual Fee Paid Amount:
213 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
20/06/2018 Power Of Attorney 1